Osborne Clarke
Osborne Clarke is noted for its ‘combination of data and IP knowledge’, which ’makes it exceptionally well positioned to advise medtech clients’. The practice centres on both advisory and contentious patent and trade secrets matters and has seen an increase in instructions relating to technology transfer deals to China. Benjamin Docquir co-heads the practice and frequently assists clients from the life sciences sector with IP transactional work. Fellow co-head Valentin De Le Court‘s practice has three core pillars: patent litigation, trade secrets issues and IP work involving China.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The IP team of Osborne Clarck is very knowledgeable, and very concerned by the clients needs. They are thus very available for their clients and provide top-quality services.’
- 'Benjamin Docquir understands complex matters and has a very good analytical mind.’
‘Osborne Clarke has abilities to manage complex IP cases in various technologies.’
‘Valentin de le Court is highly qualified in IP litigation. He provides very clear advice, and interacts smoothly with clients and external collaborators, gathering people through idea sharing.’
‘They are competent across a broad array of fields.’
‘The team has a unique combination of data and IP knowledge making it exceptionally well positioned to advise medtech clients.’
‘Valentin de le Court and Camille de Munter are both very pleasant to work with, very responsive and knowledgeable. What we particularly appreciate is their pragmatic approach.’
‘Very proactive and flexible.’
Key clients
- Généthon
Work highlights
- Representing Généthon in litigation concerning the performance of a patent license agreement signed with Novartis Gene Therapies, a Novartis Company.
Practice head
The lawyer(s) leading their teams.
Benjamin Docquir, Valentin de le Court